Suzhou CRS Pharmaceutical

Suzhou CRS Pharmaceutical is a clinical-stage biotechnology company specializing in the development of advanced drug delivery systems and long-acting formulations. The company leverages its proprietary controlled-release technology platforms to improve the pharmacokinetic profiles of existing drugs and develop new therapeutic candidates. Its primary focus areas include metabolic diseases, such as diabetes and obesity, as well as chronic pain management. By utilizing innovative formulation techniques like microspheres and lipid-based delivery, Suzhou CRS Pharmaceutical aims to reduce dosing frequency and enhance patient compliance.